Cagrilintide (10 mg) — Research Overview
Cagrilintide is a long-acting amylin analogue studied in metabolic and weight-loss peptide research in Canada. Amylin is a hormone co-secreted with insulin that plays a role in satiety and glucose regulation.
Mechanism & Research Applications
Cagrilintide is investigated for appetite regulation through amylin receptor signalling — a pathway distinct from, and complementary to, the GLP-1 system. This makes it of particular interest in research combining amylin and incretin mechanisms.
Cagrilintide is frequently studied alongside semaglutide in research examining dual-mechanism approaches to metabolic regulation.
Specifications
10 mg lyophilized powder per vial | ≥99% purity (HPLC-verified) | Batch-specific COA included
Quality & Sourcing in Canada
NuMe supplies Cagrilintide (10 mg) as part of its catalogue of weight loss peptides in Canada, research peptides in Canada, and buy peptides in Canada. Every batch is verified to ≥99% purity by HPLC, ships domestically from within Canada (typically 1–3 business days), and includes a batch-specific Certificate of Analysis. Free shipping applies to orders over $300 CAD.
Frequently Asked Questions
What is Cagrilintide studied for?
Cagrilintide is researched for appetite regulation via amylin receptor signalling, a pathway complementary to GLP-1 compounds in metabolic research.
Why is Cagrilintide studied with semaglutide?
Because amylin and GLP-1 act through different pathways, the two are researched together to study dual-mechanism approaches to metabolic regulation.
Is Cagrilintide available in Canada?
Yes, shipped domestically with a batch COA verifying ≥99% purity. For research use only.
For Research Purposes Only. This product is intended exclusively for laboratory research and in-vitro testing. It is not for human or veterinary use, consumption, or any therapeutic application.
Reviews
There are no reviews yet.